Moreover, it was shown that the use of MIM1-high and specific Mcl-1 inhibitor increased the level of Mcl-1 protein in BRAF-mutant amelanotic C32 melanoma cells with subsequent apoptosis induction [55]. This evidence concerns the gene MCL1 and melanoma.